Clinical Trials Browser

Phase EARLY_PHASE1 × Multiple Myeloma × Influenza Vaccines × Clear all

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase EARLY_PHASE1 Unknown

Multiple Myeloma, Recurrence